Autoantibodies From Connective Tissue Diseases Penetrate Cells and Exert Functional Properties
Aurélien Chepy, Celine Thiesen, M. Martel, Maithri Aspari et autres
fr, dk, gb, be (code pays fourni par la source)
0 citations
medRxiv
Esben Uggerby Næser
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
34Publications signalées
215Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Systemic Sclerosis and Related DiseasesInflammatory Myopathies and DermatomyositisMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research
Les publications récentes
Physiological responses and clinical associations of the one-minute sit-to-stand test and the six-minute walk test in systemic sclerosis
Esben Uggerby Næser, Amanda Lynggaard Elkjær, Katja Thorup Aaen, Elisabeth Bendstrup et autres
dk (code pays fourni par la source)
0 citations
Respiratory Medicine
Engaging the PD-1 pathway in systemic sclerosis attenuates inflammation-driven fibrosis
M. Aspari, Voon Ong, Klaus Søndergaard, Esben Uggerby Næser et autres
dk, gb (code pays fourni par la source)
0 citations
Annals of the Rheumatic Diseases
Intravenous immunoglobulin is an effective steroid-sparing drug in inflammatory myositis
Agnes Nannarup, Lars Erik Bartels, Esben Uggerby Næser
dk (code pays fourni par la source)
0 citations
Danish Medical Journal
POS1255 INCREASED HEALTHCARE UTILISATION IN THE FIVE YEARS PRECEDING SYSTEMIC LUPUS ERYTHEMATOSUS DIAGNOSIS: A DANISH NATIONWIDE COHORT STUDY
Sofie Geday, Anders Prior, Hans Kristian Pedersen, Annette de Thurah et autres
dk (code pays fourni par la source)
0 citations
Annals of the Rheumatic Diseases
ABS0288 ANTI-TOPOISOMERASE 1 ANTIBODY BIOACTIVITY IS ASSOCIATED WITH CLINICAL OUTCOMES IN SYSTEMIC SCLEROSIS
Celine Thiesen, Sven Petersen, Trine‐Line Korsholm, Esben Uggerby Næser et autres
dk (code pays fourni par la source)
0 citations
Annals of the Rheumatic Diseases
POS1411 ANTI-PM/SCL75 AND ANTI-PM/SCL100 ANTIBODIES ARE PATHOGENIC IN PM/SSc-OVERLAP SYNDROMES
Troels Halfeld Nielsen, Bent Deleuran, Stinne Ravn Greisen, M. Hvid et autres
dk (code pays fourni par la source)
0 citations
Annals of the Rheumatic Diseases
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors
Esben Uggerby Næser, Frederik Cosedis Enevoldsen, Simon Winther, Morten Bøttcher et autres
dk (code pays fourni par la source)
2 citations
Seminars in Arthritis and Rheumatism
Increased healthcare utilisation in the 5 years preceding systemic lupus erythematosus diagnosis: a Danish nationwide cohort study
Sofie Geday, Anders Prior, Henrik Schou Pedersen, Annette de Thurah et autres
dk (code pays fourni par la source)
2 citations
Annals of the Rheumatic Diseases
Healthcare utilization in general practice and hospitals preceding a diagnosis of systemic sclerosis: a nationwide registry study
Fie Juul Praastrup, Annette de Thurah, Ellen‐Margrethe Hauge, Linda Aagaard Rasmussen et autres
dk (code pays fourni par la source)
2 citations
Lara D. Veeken
Feasibility of a home-based exercise intervention for patients with systemic sclerosis
Peter Alsing, Mie Ladefoged Assmann, Thomas Linddal Kristensen, Esben Uggerby Næser et autres
dk (code pays fourni par la source)
0 citations
Physiotherapy Theory and Practice
COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab
Christian Gytz Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels, Cecilie Bo Hansen et autres
dk (code pays fourni par la source)
5 citations
ACR Open Rheumatology
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.